Table 3.
⊿% LBM | ⊿myostatin | ⊿adiponectin | ||||
---|---|---|---|---|---|---|
r | p | r | p | r | p | |
⊿Weight | −0.508 | < 0.001 | 0.056 | 0.655 | −0.045 | 0.718 |
⊿BMI | −0.484 | <0.001 | 0.075 | 0.547 | −0.061 | 0.626 |
⊿% fat | −0.892 | <0.001 | 0.347 | 0.004 | − 0.149 | 0.232 |
⊿% LBM | – | – | −0.359 | 0.003 | 0.102 | 0.413 |
⊿VFA | −0.363 | 0.003 | −0.012 | 0.925 | 0.041 | 0.742 |
⊿SFA | −0.519 | <0.001 | −0.101 | 0.421 | −0.092 | 0.463 |
⊿Peak VO2 | 0.315 | 0.011 | −0.101 | 0.423 | 0.022 | 0.862 |
⊿Handgrip | 0.048 | 0.709 | 0.072 | 0.577 | −0.253 | 0.047 |
⊿HOMA | −0.162 | 0.194 | −0.024 | 0.848 | 0.079 | 0.531 |
⊿Myostatin | −0.359 | 0.003 | – | – | −0.250 | 0.043 |
⊿Adiponectin | 0.102 | 0.413 | −0.250 | 0.043 | – | – |
⊿Leptin | 0.010 | 0.938 | −0.114 | 0.362 | −0.087 | 0.487 |
⊿Irisin | 0.089 | 0.180 | −0.024 | 0.851 | −0.134 | 0.282 |
Values are expressed as correlation coefficients
⊿ signifies change in the corresponding quantity
%fat, fat mass/weight × 100
%LBM, lean body mass/weight ×100
BMI body mass index, HOMA-IR homeostasis model assessment-insulin resistance, SFA subcutaneous fat area, VFA visceral fat area, VO2 oxygen consumption